Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Board of Directors of Headhunter recommended dividends

10/28/24 HEAD

Mechel reported for 9 months of 2024 by RAS

10/28/24 MTLR

MTS launched production of 5G stations

10/28/24 MTSS

DZRD reported for 9 months of 2024 by RAS

10/28/24 DZRD

INARCTICA reported for 9 months of 2024 by RAS

10/28/24 AQUA

European Electrotechnics reported for 9 months of 2024 by RAS

10/28/24 EELT

Nauka-Svyaz reported for 9 months of 2024 by RAS

10/28/24 NSVZ

KSC reported for 9 months of 2024 by RAS

10/28/24 KLSB

Nornickel reported for 9 months of 2024 by RAS

10/28/24 GMKN

Unipro's output decreased by 1%

10/28/24 UPRO